Yuan Qing Sarah 4
4 · Sigilon Therapeutics, Inc. · Filed Jul 27, 2023
Insider Transaction Report
Form 4
Yuan Qing Sarah
CTOO
Transactions
- Exercise/Conversion
Common Stock
2023-07-27$19.24/sh+2,884$55,488→ 2,884 total - Exercise/Conversion
Stock Option (Right to Buy)
2023-07-27−2,884→ 6,346 totalExercise: $19.24Exp: 2032-03-06→ Common Stock (2,884 underlying)
Footnotes (2)
- [F1]The option vested as to 25% of the underlying shares of common stock on March 7, 2023, the first anniversary of the vesting commencement date, and at a rate of 6.25% of the underlying shares thereafter on the first day of each quarter following such date until the option is fully vested.
- [F2]Effective May 22, 2023, the Issuer effected a 1-for-13 reverse stock split (the "Reverse Split") of its issued and outstanding shares of Common Stock. Cash was paid in lieu of any fractional shares resulting from the Reverse Split. The Reporting Person's beneficial ownership in this Form 4 has been adjusted for the Reverse Split.